Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions
Interventions
- DRUG: doxorubicin-eluting beads
- DRUG: sorafenib tosylate
- OTHER: laboratory biomarker analysis
- OTHER: pharmacogenomic studies
- OTHER: pharmacological study
- PROCEDURE: quality-of-life assessment
Sponsor
University College, London